http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008003854-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7c88c66ac3df895ce49114ea56ab79d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a9e6421e9257148abad101e1ce6c162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51e580668f52769520e7961a3dab188e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4188
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4353
filingDate 2007-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_550125c6e9cefdc0d8f0ee0e0bb3d140
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b33ce548362f4fa784f471f5e6cb05af
publicationDate 2008-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2008003854-A3
titleOfInvention Derivatives of 2-benzoyl-imidazopyridines, preparation method thereof and use of same in therapeutics
abstract The invention relates to derivatives having general formula (I), in which: X represents an optionally substituted phenyl group; R1 represents a hydrogen atom, a halogen, an optionally substituted (C1-C6)alkoxy group, an optionally substituted (C1-C6)alkyl group, a (C3-C7)cycloalkyl(C1-C6)alkyl group, a (C3-C7)cycloalkyl(C1-C6)alkoxy group, a hydroxy, an amino; R2 represents a hydrogen atom, an optionally substituted (C1-C6)alkyl group, an optionally substituted (C1-C6)alkoxy group, a (C3-C7)cycloalkyl(C1-C6)alkyl group, a (C3-C7)cycloalkyl(C1-C6)alkoxy group, a (C2-C6)alkenyl group, a (C2-C6)alkynyl group, a -CO-R5 group, a -CO-NR6R7 group, a -CO-O-R8 group, a -NR9-CO-R10 group, a -NR11R12 group, a halogen atom, a cyano group or an optionally substituted phenyl group; R3 represents a hydrogen atom, a (C1- C6)alkyl group or a halogen atom; and R4 represents a hydrogen atom or a halogen atom, said derivatives taking the form of a base or an acid addition salt. The invention also relates to the preparation method thereof and to the use of same in therapeutics.
priorityDate 2006-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03059884-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2638161-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004204409-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0174813-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005044793-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12238409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421025033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 42.